March 3, 2020 - Bloomfield Hills, MI - Pure Green Pharmaceuticals announced today that Dr. Debra Kimless, Chief Medical Officer, was selected as the 2020 ASA Medical Professional of the Year award winner by Americans for Safe Access. She will be honored at this year's Unity Awards Dinner on Friday, March 27 during the National Medical Cannabis Unity Conference in Washington, D.C.
Steve Goldner, Esq, R.A.C., CEO of Pure Green Pharmaceuticals proudly states, “Dr. Kimless’s tireless efforts for patients’ rights and access to medication inspires everyone at Pure Green Pharmaceuticals. She constantly gives of herself to patients and their families, and then redoubles her efforts to educate medical professionals and laypersons, government officials and so many others. We thank Americans For Safe Access for having recognized Dr. Kimless as the consummate medical professional.”
As a board-certified anesthesiologist and pain medicine specialist, Dr. Kimless focuses on the pain-relieving aspects of cannabinoids and related substances for our FDA drug development program. Her recent election to the Board of Directors of the International Association for Cannabinoid Medicine has given her a world-wide educational platform for cannabis medicine.
About Pure Green Pharmaceuticals
PGP uses selected cannabinoid molecules as the active ingredient in its unique water soluble sublingual tablets. The tablets will be studied in FDA-regulated clinical trials for major therapeutic purposes including diabetic neuropathy pain relief, osteoarthritis pain relief and PTSD pain and anxiety relief. The tablets are expected to provide reliable, consistent, accurate medication in a regulatory compliant dosage form. The company’s mission is to obtain regulatory approval throughout the world so that physicians can provide medical treatment to their patients. https://pgpharma.co/
About Americans for Safe Access
Americans for Safe Access (ASA) was founded to ensure safe and legal access to cannabis for therapeutic use and research. ASA was founded in 2002, the organization has over 100,000 active members in all 50 states and is the largest national member-based organization of patients, medical professionals, scientists and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research. ASA works to overcome political, social and legal barriers by creating policies that improve access to medical cannabis for patients and researchers through legislation, education, litigation, research, grassroots empowerment, advocacy and services for patients, governments, medical professionals, and medical cannabis providers. Americans for Safe Access